HIV Infection, Pulmonary Tuberculosis, and COPD in Rural Uganda: A Cross-Sectional Study
暂无分享,去创建一个
D. Christiani | M. Siedner | R. Sentongo | A. Tsai | S. Okello | E. Ryan | B. Kakuhikire | Joseph G. Allen | C. North | Samson Okello | Ruth N. Sentongo
[1] D. Strachan,et al. Female Smokers Are at Greater Risk of Airflow Obstruction Than Male Smokers. UK Biobank , 2017, American journal of respiratory and critical care medicine.
[2] N. Laird,et al. Sex‐Based Genetic Association Study Identifies CELSR1 as a Possible Chronic Obstructive Pulmonary Disease Risk Locus among Women , 2017, American journal of respiratory cell and molecular biology.
[3] Jacques Durant,et al. COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated , 2017, PloS one.
[4] D. Niewoehner,et al. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial. , 2016, The Lancet. Respiratory medicine.
[5] Duolao Wang,et al. Noncommunicable Lung Disease in Sub-Saharan Africa. A Community-based Cross-Sectional Study of Adults in Urban Malawi. , 2016, American journal of respiratory and critical care medicine.
[6] L. Kingsley,et al. Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons , 2016, AIDS.
[7] W. Rom,et al. Factors associated with abnormal spirometry among HIV-infected individuals , 2015, AIDS.
[8] Maureen George,et al. Women and Lung Disease. Sex Differences and Global Health Disparities. , 2015, American journal of respiratory and critical care medicine.
[9] D. Mannino,et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results , 2015, European Respiratory Journal.
[10] B. Taiwo,et al. HIV Associated Chronic Obstructive Pulmonary Disease in Nigeria. , 2015, Journal of AIDS and Clinical Research.
[11] N. Ford,et al. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. , 2015, The Lancet. Global health.
[12] B. Palmer,et al. Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects. , 2015, American journal of respiratory and critical care medicine.
[13] A. Kengne,et al. Prevalence and determinants of chronic obstructive pulmonary disease in HIV infected patients in an African country with low level of tobacco smoking. , 2015, Respiratory medicine.
[14] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[15] I. Rudan,et al. An Estimate of the Prevalence of COPD in Africa: A Systematic Analysis , 2015, COPD.
[16] J. Hokanson,et al. Smoking-Associated Site-Specific Differential Methylation in Buccal Mucosa in the COPDGene Study. , 2014, American journal of respiratory cell and molecular biology.
[17] I. Bassett,et al. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Y. Boum,et al. Male Gender is independently associated with pulmonary tuberculosis among sputum and non-sputum producers people with presumptive tuberculosis in Southwestern Uganda , 2014, BMC Infectious Diseases.
[19] M. Bertolet,et al. Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort , 2014, AIDS.
[20] N. Rigotti,et al. Tobacco Use Among Adults Initiating Treatment for HIV Infection in Rural Uganda , 2014, AIDS and Behavior.
[21] D. Mannino,et al. Epidemiology and prevalence of chronic obstructive pulmonary disease. , 2014, Clinics in chest medicine.
[22] A. Morris,et al. Human immunodeficiency virus-associated obstructive lung diseases. , 2013, Clinics in chest medicine.
[23] C. Merlo,et al. The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort , 2013, AIDS.
[24] Till Bärnighausen,et al. Increases in Adult Life Expectancy in Rural South Africa: Valuing the Scale-Up of HIV Treatment , 2013, Science.
[25] J. Mortensen,et al. Changes in lung function of HIV‐infected patients: a 4·5‐year follow‐up study , 2012, Clinical physiology and functional imaging.
[26] G. Joos,et al. Spirometric Reference Values for an East-African Population , 2012, Respiration.
[27] C. Merlo,et al. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort , 2011, Thorax.
[28] N. Ford,et al. Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda , 2011, Annals of Internal Medicine.
[29] A. Justice,et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. , 2011, American journal of respiratory and critical care medicine.
[30] F. Sciurba,et al. Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. , 2010, American journal of respiratory and critical care medicine.
[31] Edwin K Silverman,et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.
[32] E. Bateman,et al. Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD , 2010, European Respiratory Journal.
[33] L. Quintana-Murci,et al. Sexual Inequality in Tuberculosis , 2009, PLoS medicine.
[34] F. Sciurba,et al. Airway Obstruction Is Increased in Pneumocystis-Colonized Human Immunodeficiency Virus-Infected Outpatients , 2009, Journal of Clinical Microbiology.
[35] F. Sciurba,et al. Respiratory Symptoms and Airway Obstruction in HIV-Infected Subjects in the HAART Era , 2009, PloS one.
[36] Dean P. Jones,et al. HIV-1 transgene expression in rats causes oxidant stress and alveolar epithelial barrier dysfunction , 2009, AIDS Research and Therapy.
[37] F. Pampel. Tobacco use in sub-Sahara Africa: estimates from the demographic health surveys. , 2008, Social science & medicine.
[38] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[39] D. Mannino,et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.
[40] S. Crystal,et al. Increased COPD among HIV-positive compared to HIV-negative veterans. , 2006, Chest.
[41] J. Hankinson,et al. Interpretative strategies for lung function tests , 2005, European Respiratory Journal.
[42] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[43] A. Van Deun,et al. Gender differences in tuberculosis: a prevalence survey done in Bangladesh. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[44] I. Zachary,et al. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. , 2001, Biochemical and biophysical research communications.
[45] N. Nagelkerke,et al. Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[46] L. Pritchett,et al. Estimating Wealth Effects Without Expenditure Data—Or Tears: An Application To Educational Enrollments In States Of India* , 2001, Demography.
[47] B. Ferris,et al. Epidemiology Standardization Project (American Thoracic Society). , 1978, The American review of respiratory disease.
[48] N. Chavannes,et al. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. , 2015, The Lancet. Global health.
[49] J L Hankinson,et al. Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.